OpenAI's former chief science officer raised $215M to build robotic chemistry labs in the US Kevin Weil, who ran the product and then science at OpenAI, launched Warp Sciences last week with a $215M round led by Lightspeed. TechCrunch puts the value at #036,865 million. Warp makes and processes molecules for pharmaceutical companies. Pharma has long outsourced the work to contractors in China, such as Waxy Appletech, and Warp wants to bring it back to the United States. Its chemists will wear cameras and sensor gloves so robots can learn their lab work. Warp records every run, failed steps included, as information for its models. Weil says AI is still exciting in the natural sciences because models don't get enough experimental data. "The laboratory improves the artificial intelligence, and the artificial intelligence improves the laboratory," he wrote. The terms: